Bayer Revenue 2010-2023 | BAYRY

Bayer revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bayer Annual Revenue
(Millions of US $)
2022 $53,459
2021 $52,152
2020 $47,291
2019 $48,770
2018 $46,751
2017 $39,577
2016 $51,755
2015 $51,438
2014 $56,148
2013 $53,341
2012 $51,135
2011 $50,876
2010 $46,593
2009 $43,467
Bayer Quarterly Revenue
(Millions of US $)
2023-06-30 $12,042
2023-03-31 $15,445
2022-12-31 $12,027
2022-09-30 $11,362
2022-06-30 $13,642
2022-03-31 $16,428
2021-12-31 $12,678
2021-09-30 $11,534
2021-06-30 $13,078
2021-03-31 $14,863
2020-12-31 $12,107
2020-09-30 $9,944
2020-06-30 $11,070
2020-03-31 $14,171
2019-12-31 $10,148
2019-09-30 $10,931
2019-06-30 $12,909
2019-03-31 $14,782
2018-12-31 $12,695
2018-09-30 $11,517
2018-06-30 $11,307
2018-03-31 $11,232
2017-12-31 $4,102
2017-09-30 $9,432
2017-06-30 $13,411
2017-03-31 $12,633
2016-12-31 $12,646
2016-09-30 $12,568
2016-06-30 $13,367
2016-03-31 $13,173
2015-12-31 $12,109
2015-09-30 $12,279
2015-06-30 $13,374
2015-03-31 $13,676
2014-12-31 $13,819
2014-09-30 $13,517
2014-06-30 $14,346
2014-03-31 $14,466
2013-12-31 $13,477
2013-09-30 $12,774
2013-06-30 $13,529
2013-03-31 $13,560
2012-12-31 $12,779
2012-09-30 $12,095
2012-06-30 $13,078
2012-03-31 $13,183
2011-12-31 $12,366
2011-09-30 $12,277
2011-06-30 $13,314
2011-03-31 $12,870
2010-12-31 $12,390
2010-09-30 $11,069
2010-06-30 $11,712
2010-03-31 $10,969
2009-12-31 $11,282
2009-09-30 $11,087
2009-06-30 $10,908
2009-03-31 $10,327
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $0.000B $53.468B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $524.286B 70.81
Johnson & Johnson (JNJ) United States $416.511B 15.44
Novo Nordisk (NVO) Denmark $408.949B 43.19
AbbVie (ABBV) United States $272.964B 12.24
Merck (MRK) United States $268.571B 37.67
Novartis AG (NVS) Switzerland $215.796B 15.36
AstraZeneca (AZN) United Kingdom $213.700B 19.31
Pfizer (PFE) United States $186.204B 6.84
Sanofi (SNY) $137.454B 12.27
Innoviva (INVA) United States $0.850B 9.67